CXI Healthcare Announces 5.5M Share Third-Party Rights Issue, Diluting Existing Shares by 49% with 1-Year Lock-Up

On July 1, 2026, CXI Healthcare Technology Group Limited's board resolved a third-party allotment rights offering, issuing 5.5 million new common shares at 1,200 KRW per share, a 9.68% premium over the reference price but slightly above the current market price of 1,126 KRW.
The issuance increases total shares from 11,169,660 to 16,669,660, diluting existing shareholders by approximately 49.2%. The expected proceeds of about 66 billion KRW will be used for operating funds including tea plantation development, labor, and marketing costs.
All allotted shares are subject to a 1-year lock-up with Korea Securities Depository. The investors are individuals LIU HUAN, ZHANG DONGXIAN, and LIN QIANG, none affiliated with the company. The company cited restrictions on transferring funds from Chinese subsidiaries as a key reason for the capital raise.
[AI Summary]CXI Healthcare's massive 49% equity dilution to raise operating funds signals urgent near-term liquidity needs despite a slight issuance premium. The lack of high-return project details and the opaque individual counterparties suggest high investment risk, likely weighing on the stock price.